Report Detail
Global (United States, European Union and China) Montelukast Drug Market Research Report 2019-2025
- RnM3689812 |
- 22 August, 2019 |
- Global |
- 120 Pages |
- QYResearch |
- Pharma & Healthcare
Montelukast is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.
In 2019, the market size of Montelukast Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Montelukast Drug.
This report studies the global market size of Montelukast Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Montelukast Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Merck & Co.
Teva
Mylan
Glenmark Pharmaceuticals
Hikma Group
Sandoz
Torrent Pharmaceuticals
Lannett Company
Apotex
Dr. Reddys Laboratories
Aurobindo Pharma
Accord Healthcare
Hetero
Unimark
Ajanta Pharma
MACLEODS
Jubilant Pharma
Unichem Laboratories
Amneal Pharmaceuticals
Shanghai Anbison Lab
Perrigo
Cipla
CSPC Ouyi Pharmaceutical
Market Segment by Product Type
Tablet
Chewable tablet
Oral Granules
Market Segment by Application
Hospital
Drug store
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Montelukast Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Montelukast Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Montelukast Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Montelukast Drug Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Tablet
- 1.3.3 Chewable tablet
- 1.3.4 Oral Granules
- 1.4 Market Segment by Application
- 1.4.1 Global Montelukast Drug Market Share by Application (2019-2025)
- 1.4.2 Hospital
- 1.4.3 Drug store
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Montelukast Drug Market Size
- 2.1.1 Global Montelukast Drug Revenue 2014-2025
- 2.1.2 Global Montelukast Drug Sales 2014-2025
- 2.2 Montelukast Drug Growth Rate by Regions
- 2.2.1 Global Montelukast Drug Sales by Regions 2014-2019
- 2.2.2 Global Montelukast Drug Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Montelukast Drug Sales by Manufacturers
- 3.1.1 Montelukast Drug Sales by Manufacturers 2014-2019
- 3.1.2 Montelukast Drug Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Montelukast Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Montelukast Drug Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Montelukast Drug Market Concentration Ratio (CR5 and HHI)
- 3.3 Montelukast Drug Price by Manufacturers
- 3.4 Key Manufacturers Montelukast Drug Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Montelukast Drug Market
- 3.6 Key Manufacturers Montelukast Drug Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Tablet Sales and Revenue (2014-2019)
- 4.1.2 Chewable tablet Sales and Revenue (2014-2019)
- 4.1.3 Oral Granules Sales and Revenue (2014-2019)
- 4.2 Global Montelukast Drug Sales Market Share by Type
- 4.3 Global Montelukast Drug Revenue Market Share by Type
- 4.4 Montelukast Drug Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Montelukast Drug Sales by Application
6 United States
- 6.1 United States Montelukast Drug Breakdown Data by Company
- 6.2 United States Montelukast Drug Breakdown Data by Type
- 6.3 United States Montelukast Drug Breakdown Data by Application
7 European Union
- 7.1 European Union Montelukast Drug Breakdown Data by Company
- 7.2 European Union Montelukast Drug Breakdown Data by Type
- 7.3 European Union Montelukast Drug Breakdown Data by Application
8 China
- 8.1 China Montelukast Drug Breakdown Data by Company
- 8.2 China Montelukast Drug Breakdown Data by Type
- 8.3 China Montelukast Drug Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Montelukast Drug Breakdown Data by Company
- 9.2 Rest of World Montelukast Drug Breakdown Data by Type
- 9.3 Rest of World Montelukast Drug Breakdown Data by Application
- 9.4 Rest of World Montelukast Drug Breakdown Data by Countries
- 9.4.1 Rest of World Montelukast Drug Sales by Countries
- 9.4.2 Rest of World Montelukast Drug Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Merck & Co.
- 10.1.1 Merck & Co. Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Montelukast Drug
- 10.1.4 Montelukast Drug Product Introduction
- 10.1.5 Merck & Co. Recent Development
- 10.2 Teva
- 10.2.1 Teva Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Montelukast Drug
- 10.2.4 Montelukast Drug Product Introduction
- 10.2.5 Teva Recent Development
- 10.3 Mylan
- 10.3.1 Mylan Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Montelukast Drug
- 10.3.4 Montelukast Drug Product Introduction
- 10.3.5 Mylan Recent Development
- 10.4 Glenmark Pharmaceuticals
- 10.4.1 Glenmark Pharmaceuticals Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Montelukast Drug
- 10.4.4 Montelukast Drug Product Introduction
- 10.4.5 Glenmark Pharmaceuticals Recent Development
- 10.5 Hikma Group
- 10.5.1 Hikma Group Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Montelukast Drug
- 10.5.4 Montelukast Drug Product Introduction
- 10.5.5 Hikma Group Recent Development
- 10.6 Sandoz
- 10.6.1 Sandoz Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Montelukast Drug
- 10.6.4 Montelukast Drug Product Introduction
- 10.6.5 Sandoz Recent Development
- 10.7 Torrent Pharmaceuticals
- 10.7.1 Torrent Pharmaceuticals Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Montelukast Drug
- 10.7.4 Montelukast Drug Product Introduction
- 10.7.5 Torrent Pharmaceuticals Recent Development
- 10.8 Lannett Company
- 10.8.1 Lannett Company Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Montelukast Drug
- 10.8.4 Montelukast Drug Product Introduction
- 10.8.5 Lannett Company Recent Development
- 10.9 Apotex
- 10.9.1 Apotex Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Montelukast Drug
- 10.9.4 Montelukast Drug Product Introduction
- 10.9.5 Apotex Recent Development
- 10.10 Dr. Reddys Laboratories
- 10.10.1 Dr. Reddys Laboratories Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Montelukast Drug
- 10.10.4 Montelukast Drug Product Introduction
- 10.10.5 Dr. Reddys Laboratories Recent Development
- 10.11 Aurobindo Pharma
- 10.12 Accord Healthcare
- 10.13 Hetero
- 10.14 Unimark
- 10.15 Ajanta Pharma
- 10.16 MACLEODS
- 10.17 Jubilant Pharma
- 10.18 Unichem Laboratories
- 10.19 Amneal Pharmaceuticals
- 10.20 Shanghai Anbison Lab
- 10.21 Perrigo
- 10.22 Cipla
- 10.23 CSPC Ouyi Pharmaceutical
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Montelukast Drug Sales Channels
- 11.2.2 Montelukast Drug Distributors
- 11.3 Montelukast Drug Customers
12 Market Forecast
- 12.1 Global Montelukast Drug Sales and Revenue Forecast 2019-2025
- 12.2 Global Montelukast Drug Sales Forecast by Type
- 12.3 Global Montelukast Drug Sales Forecast by Application
- 12.4 Montelukast Drug Forecast by Regions
- 12.4.1 Global Montelukast Drug Sales Forecast by Regions 2019-2025
- 12.4.2 Global Montelukast Drug Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Montelukast Drug. Industry analysis & Market Report on Montelukast Drug is a syndicated market report, published as Global (United States, European Union and China) Montelukast Drug Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Montelukast Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
